HB683: AN ACT relating to coverage for the treatment of postpartum mood disorders.
Legislative Summary
Create a new section of Subtitle 17A of KRS Chapter 304 to require health benefit plans to provide coverage for FDA-approved prescription drugs for the treatment of postpartum mood disorders; allow the suspension of the coverage requirement for FDA-approved prescription drugs for the treatment of postpartum mood disorders under qualified health plans if cost defrayment required by the state; amend KRS 205.522, 205.6485, 18A.225, and 164.2871 to require Medicaid, Kentucky Children's Health Insurance Program, the state health employee health plan, and a self-insured employer group health plan provided by a state postsecondary education institution to its employees to comply; direct that provisions apply to health benefit plans issued on or after January 1, 2026; EFFECTIVE January 1, 2026.
Demographic Impact
Overall analysis of equity impact
Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
